Cargando…
In vitro-generated alloantigen-specific Th9 cells mediate antileukemia cytotoxicity in the absence of graft-versus-host disease
Autores principales: | Reisser, Tanja, Halbgebauer, Daniel, Scheurer, Jasmin, Wolf, Linda, Leithäuser, Frank, Beyersdorf, Niklas, Fischer-Posovszky, Pamela, Debatin, Klaus-Michael, Strauss, Gudrun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326704/ https://www.ncbi.nlm.nih.gov/pubmed/32034284 http://dx.doi.org/10.1038/s41375-020-0731-2 |
Ejemplares similares
-
Rapamycin‐based graft‐versus‐host disease prophylaxis increases the immunosuppressivity of myeloid‐derived suppressor cells without affecting T cells and anti‐tumor cytotoxicity
por: Scheurer, J., et al.
Publicado: (2020) -
Repurposing immunosuppressants for antileukemia therapy
por: Sezaki, Maiko, et al.
Publicado: (2022) -
Graft-Versus-Host Disease Prevention by In Vitro-Generated Myeloid-Derived Suppressor Cells Is Exclusively Mediated by the CD11b+CD11c+ MDSC Subpopulation
por: Scheurer, Jasmin, et al.
Publicado: (2021) -
miR-146a regulates insulin sensitivity via NPR3
por: Roos, Julian, et al.
Publicado: (2020) -
Semi-Synthesis, Cytotoxic Evaluation, and Structure—Activity Relationships of Brefeldin A Derivatives with Antileukemia Activity
por: Lu, Xu-Xiu, et al.
Publicado: (2021)